Milrinone Lactate (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Milrinone Lactate drug offered from Fresenius Kabi USA, LLC. This Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: MILRINONE LACTATE
SUBSTANCE NAME: MILRINONE LACTATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2002-08-01
END MARKETING DATE: 0000-00-00


Milrinone Lactate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMilrinone Lactate from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2002-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-617_51198ebd-2896-438a-ba9d-db32aa171bf2
PRODUCT NDC: 63323-617
APPLICATION NUMBER: ANDA075936

Other MILRINONE LACTATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationMilrinone Lactate in Dextrose
Fresenius Kabi USA, LLCMilrinone Lactate
Gland Pharma LimitedMilrinone Lactate
Hospira, Inc.MILRINONE LACTATE
West-ward Pharmaceutical CorpMilrinone Lactate
West-ward Pharmaceutical Corp.Milrinone Lactate
West-Ward Pharmaceuticals CorpMilrinone Lactate in Dextrose